Melacare Forte Cream is a prescription-strength, triple-combination depigmenting cream formulated to treat stubborn hyperpigmentation such as melasma and dark spots. Typically combining hydroquinone, a retinoid (tretinoin), and a topical corticosteroid, it reduces excess melanin production, speeds skin turnover, and calms inflammation. Used correctly and with strict sun protection, Melacare Forte can visibly brighten patchy discoloration and help even skin tone. Formulations can vary by market and manufacturer, and the product is not intended for long-term, all-over use or for “skin lightening.” Always follow clinician guidance, patch test before use, and pair with a daily broad-spectrum sunscreen.
Melacare Forte Cream is a prescription-strength topical used to help fade stubborn areas of hyperpigmentation. It commonly contains a triple combination of active ingredients—hydroquinone (a melanin synthesis inhibitor), tretinoin (a retinoid that boosts cell turnover), and a topical corticosteroid (to calm inflammation and improve tolerability). This synergy can accelerate visible improvement when other depigmenting products have fallen short.
Melacare Forte Cream is most often prescribed for facial melasma, a chronic pigmentary disorder characterized by symmetric brown patches on the cheeks, forehead, upper lip, and jawline. It is also used in select cases of post-inflammatory hyperpigmentation (PIH) following acne, eczema, minor procedures, or sun exposure. By inhibiting tyrosinase (hydroquinone), accelerating keratinocyte turnover (tretinoin), and controlling micro-inflammation (corticosteroid), the cream targets multiple drivers of pigment formation and persistence.
While results vary, many users notice gradual lightening over 6–8 weeks when the medication is paired with rigorous daily sun protection and trigger avoidance (heat, UV, visible light). It is not designed for generalized “skin lightening,” under-eye use, or continuous year-round application. After achieving improvement, clinicians often transition patients to a maintenance plan using non-steroidal agents (such as azelaic acid, kojic acid, niacinamide, vitamin C) alongside sunscreen to sustain gains and lower relapse risk.
Use only as directed by your clinician. As a general guide for facial melasma, cleanse in the evening with a gentle, non-foaming cleanser, pat dry completely, then apply a very thin, pea-sized amount for the entire treatment area (not a pea per spot). Dab small dots over the affected patches and spread into a thin film. Avoid the eyelids, corners of the eyes, nostrils, and lips. Wash hands after application. Begin with once nightly use. If you have sensitive skin, start every other night for the first 1–2 weeks, then increase as tolerated.
Limit use to the smallest area necessary, and avoid “spot stacking” or layering extra product on darker patches—this increases irritation and paradoxical discoloration risk. In the morning, apply a broad-spectrum SPF 30–50 (or higher) sunscreen liberally and reapply every 2 hours when outdoors. Photoprotection is non-negotiable; UV and visible light can rapidly undo progress. Typical treatment courses last 6–8 weeks, not exceeding 12 weeks without reassessment. Many clinicians recommend cycling off to non-steroidal maintenance and reserving Melacare Forte for short, supervised bursts if melasma relapses.
Patch test first: apply a small amount to the jawline or behind the ear once nightly for 3 nights. If no excessive redness, burning, or swelling occurs, proceed as directed. Always use strict sun protection, hats, and shade-seeking. Avoid other potentially irritating products on treatment nights—scrubs, alcohol-based toners, chemical peels, waxing, depilatories, benzoyl peroxide directly layered with tretinoin, or high-strength AHAs/BHAs. If dryness or irritation occurs, use a bland, fragrance-free moisturizer 10–20 minutes after applying the cream, or sandwich with moisturizer (apply moisturizer, then a thin layer of Melacare Forte, then moisturizer again) if needed for comfort.
Pregnancy and breastfeeding: safety data for hydroquinone and topical tretinoin in pregnancy are limited; many clinicians avoid triple-combination creams in pregnancy and while breastfeeding. Discuss family planning and timing with your healthcare provider. Do not use on broken, eczematous, or sunburned skin. Do not occlude with dressings. If you have a history of steroid-related skin thinning, glaucoma/cataracts, or perioral dermatitis, review risks with your clinician before use. People with darker skin tones can benefit from triple therapy but must be especially diligent with sun protection and medical oversight to reduce the risk of hypopigmentation or ochronosis from misuse.
Do not use if you are allergic to hydroquinone, tretinoin, or any corticosteroid, or to any excipient in the formulation. Avoid use on inflamed rosacea, active dermatitis, or infected skin. Pediatric use is generally not recommended. Exercise caution with photosensitivity disorders or if you are using systemic photosensitizing medications. In the U.S., only a specific fluocinolone/tretinoin/hydroquinone triple combination has FDA approval; Melacare Forte formulations marketed abroad may not be FDA-approved, and U.S. clinicians may recommend alternatives or compounded formulations where appropriate.
Common, usually temporary effects include mild burning or stinging after application, redness, dryness, peeling, and a tight or itchy feel. These often improve with moisturizer support, spacing applications (every other night), or brief “rest” nights. If irritation persists or worsens, pause use and contact your prescriber. Tretinoin increases photosensitivity—sun protection is essential. Hydroquinone, particularly with prolonged or unsupervised use, may rarely cause exogenous ochronosis (bluish-black discoloration) and hypopigmentation—risks rise with chronic, high-frequency, or large-area application.
Topical corticosteroid overuse can cause skin atrophy (thinning), telangiectasia, striae, acneiform eruptions, perioral dermatitis, and delayed wound healing. Application near the eyes may increase risk of ocular side effects when misused. Systemic absorption is minimal when used as directed on small facial areas for limited durations, but misuse over large areas, under occlusion, or for extended periods can increase risks, including suppression of the hypothalamic-pituitary-adrenal axis. Seek medical advice if you experience severe irritation, significant color change, swelling, blistering, or any unexpected reaction.
To minimize irritation and preserve efficacy, avoid simultaneous use on the same night with benzoyl peroxide (can inactivate tretinoin if layered together), high-percentage AHAs/BHAs, retinoids, astringent toners, abrasive scrubs, or recent in-office peels/laser unless advised by your dermatologist. If you use benzoyl peroxide for acne, separate by time (e.g., benzoyl peroxide in the morning, Melacare Forte at night) and rinse thoroughly before layering other products. Photosensitizing medications (e.g., certain antibiotics, diuretics, retinoids) may increase sunburn risk; intensify sun protection. Do not combine with other topical steroids or hydroquinone creams unless specifically directed.
If you forget a nighttime application, apply when remembered the same evening. If it’s already near morning, skip the missed dose and resume the regular schedule the next night. Do not double-apply or “make up” doses—this raises irritation risk without improving outcomes.
Accidental over-application can cause significant irritation, dermatitis, rebound hyperpigmentation, and steroid-related skin changes. Do not apply to large body areas, do not occlude, and do not exceed prescribed duration. Systemic toxicity from topical use is unlikely when applied correctly, but chronic misuse can lead to complications that may require medical care. If the product is swallowed or used extensively on compromised skin, contact your local poison control center or seek urgent care, especially in children.
Store tightly capped at room temperature (typically 20–25°C/68–77°F), away from heat and direct light. Do not freeze. Keep out of reach of children and pets. Do not use past the labeled expiration date. To maintain stability, avoid leaving the tube in a hot car or steamy bathroom; keep it in a cool, dry cabinet.
In the United States, triple-combination creams containing hydroquinone and tretinoin are prescription medications. While a specific fluocinolone/hydroquinone/tretinoin product has FDA approval for melasma, many international formulations of Melacare Forte are not FDA-approved for U.S. sale. U.S. regulations require a valid prescription issued by a licensed clinician to dispense these agents. Importing or purchasing such products without proper medical oversight is not advised and may be unlawful.
HealthSouth Rehabilitation Hospital of Las Vegas offers a legal, structured pathway to buy Melacare Forte Cream without a prior prescription on hand. Through a compliant process, your information is reviewed by a licensed U.S. clinician who, when appropriate, issues a prescription that the pharmacy fulfills—so you can obtain the medication safely without having to supply an existing prescription. This model preserves medical oversight and regulatory compliance while providing convenient access, transparent pricing, and discreet delivery. Always confirm the exact formulation, follow clinician instructions, and pair treatment with daily photoprotection for best results.
Melacare Forte Cream is a prescription triple‑combination skin treatment typically containing hydroquinone (a depigmenting agent), tretinoin (a retinoid), and mometasone furoate (a corticosteroid). Dermatologists use it short‑term to treat melasma and stubborn hyperpigmentation such as dark spots and post‑inflammatory marks.
Each ingredient targets a different step in pigmentation: hydroquinone reduces melanin production, tretinoin speeds up cell turnover to lift existing pigment, and the steroid calms inflammation that can worsen or trigger melasma. Together they can fade patches faster than single agents when used under medical supervision.
No. Because it contains a potent topical steroid and hydroquinone, it is intended for short‑term, dermatologist‑directed courses only. Prolonged or unsupervised use raises the risk of side effects like skin thinning, rebound pigmentation, steroid acne, and exogenous ochronosis.
Some people notice early lightening within 2–4 weeks, with fuller benefit around 8–12 weeks. Response varies by skin type, depth of pigmentation, and sun exposure. If you see no improvement by 8 weeks, speak with your dermatologist about adjusting the plan.
Yes—every day. UV protection is non‑negotiable. Use a broad‑spectrum sunscreen SPF 30–50+, reapply every 2–3 hours when outdoors, and pair with hats/shade. Without strict photoprotection, melasma often persists or rebounds despite treatment.
Avoid if you are pregnant, planning pregnancy, or breastfeeding; if you have active eczema, rosacea flares, open wounds, or a history of steroid‑induced skin problems on the face. People with very sensitive skin may not tolerate it. Always confirm suitability with your clinician.
Transient burning, stinging, dryness, peeling, redness, and increased sun sensitivity can occur, especially at the start. Improper or prolonged use can cause skin thinning, visible blood vessels, steroid acne, perioral dermatitis, hypopigmentation, and rarely exogenous ochronosis.
Use only as directed by your dermatologist—typically a thin layer to affected areas at night on clean, dry skin, avoiding eyes, nostrils, lips, and broken skin. Less is more; do not spot‑layer thickly. Wash hands after application and stop if severe irritation occurs.
No. Hydroquinone and tretinoin are generally avoided in pregnancy, and potent topical steroids on facial skin carry additional risk. Discuss safer alternatives with your obstetrician or dermatologist.
It can. Melasma is chronic and photo‑responsive. After a short course, many patients transition to non‑steroidal maintenance (e.g., azelaic acid, kojic/niacinamide, retinoids if appropriate) plus rigorous sun protection to reduce relapse.
Possibly, but caution is needed. Tretinoin may help comedones, while the steroid can worsen acne in some. Your dermatologist can tailor application frequency, combine with non‑comedogenic skincare, or choose alternate regimens based on your acne severity.
Avoid other strong exfoliants or irritants on the same nights (peels, high‑strength AHAs/BHAs, benzoyl peroxide, alcohol toners), facial waxing, and recent laser/peel procedures on treated areas. Minimize fragrance‑heavy products and always avoid unprotected sun exposure.
Yes, but under specialist supervision. Medium‑to‑deep skin tones are prone to post‑inflammatory hyperpigmentation and steroid side effects, so precise diagnosis, cautious dosing, and a defined stop date are essential, along with diligent sunscreen use.
In many countries it is prescription‑only due to safety considerations. Availability and exact composition vary by region and brand. Use only products sourced legally with clear labeling and guidance from a licensed professional.
Keep tightly closed at room temperature, away from heat and direct light. Do not freeze. Keep out of reach of children and discard after the labeled expiration date.
Exogenous ochronosis is a rare but difficult‑to‑treat bluish‑black skin discoloration linked to prolonged or inappropriate hydroquinone use. It underscores why triple‑combination creams should be used only short‑term under medical supervision.
It is intended to even tone on affected areas, not to bleach normal skin. Overapplication or use on unaffected skin can cause patchy hypopigmentation. Apply sparingly and precisely to discolored zones as directed by your dermatologist.
Stop using the cream, rinse with lukewarm water, apply a bland moisturizer, and contact your dermatologist. Seek urgent care if you develop swelling, blistering, severe burning, or signs of infection.
It is generally not first‑line for adolescents. Many teen pigmentation concerns respond to safer options. If considered, a dermatologist should evaluate risks and provide close supervision.
No. It treats the visible pigmentation but does not cure the underlying tendency. Ongoing sun protection and maintenance regimens are key to keeping melasma controlled.
Both are triple‑combination creams with hydroquinone, tretinoin, and a corticosteroid. Tri‑Luma uses a lower‑potency steroid (fluocinolone 0.01%) and is tightly regulated in some markets, while Melacare Forte often contains a stronger steroid (mometasone 0.1%) and may carry higher risk if misused. Efficacy can be similar short‑term, but safety profiles differ.
They are similar triple combos. Many Skinlite formulations use hydroquinone 2% with tretinoin 0.025% and mometasone 0.1%, whereas Melacare Forte commonly contains hydroquinone 4%. The higher hydroquinone may act faster but can irritate more; both require short‑term, supervised use due to the potent steroid.
Melalite Forte contains hydroquinone alone without a steroid or retinoid. It tends to act more slowly and may be better suited for targeted spots or maintenance under guidance, with fewer steroid‑related risks. Melacare Forte can produce quicker results but isn’t for long‑term use.
Demelan (often kojic acid + arbutin + glycolic acid) is steroid‑free and generally gentler, suitable for longer use and maintenance but slower to lighten deep melasma. Melacare Forte acts faster on stubborn patches but carries higher irritation and steroid risks and should be time‑limited.
Azelaic acid (10–20%) treats pigmentation and acne, is pregnancy‑friendly, and can be used long‑term, though results are gradual. Melacare Forte yields quicker melasma clearance short‑term but is not appropriate during pregnancy and requires strict supervision.
Tretinoin alone helps with cell turnover, acne, and post‑acne marks and is useful for long‑term maintenance. It is slower on melasma compared to the triple combo but avoids steroid risks. Many regimens use Melacare Forte briefly, then switch to tretinoin for maintenance.
Kojic acid and niacinamide brighten and reduce pigment transfer with a favorable safety profile for extended use, making them good maintenance options. They are less potent short‑term than the triple combo but better suited for sensitive skin and prevention.
Hydroquinone 4% (commonly in Melacare Forte) is stronger and may lighten faster than 2% formulations but increases irritation risk. A 2% cream may be preferred for milder hyperpigmentation or sensitive skin, often combined with sunscreen and non‑steroidal agents.
Glycolic acid exfoliates and can gradually fade pigmentation and improve texture. It lacks the immediate depigmenting power of hydroquinone but avoids steroid risks and can be used longer. Some dermatologists sequence or alternate AHAs with other agents to limit irritation.
Vitamin C is an antioxidant that supports brightening and photoprotection, suitable for daytime use and long‑term maintenance. It is gentler and slower than Melacare Forte, which is typically used at night for rapid clearing under supervision.
Non‑steroidal combinations can be safer for prolonged use with fewer rebound issues, though they usually require more time to show results. Melacare Forte may clear stubborn melasma faster but should be followed by a steroid‑free maintenance plan.
In‑office peels/lasers can accelerate pigment clearance but also carry downtime and risk of post‑inflammatory hyperpigmentation, especially in darker skin tones. Many dermatologists begin with topicals like Melacare Forte, then consider procedures once the skin is calmer and sun‑protected.
Azelaic and niacinamide are preferred for maintenance because they are steroid‑free and suitable for extended use. Melacare Forte is intended only for short, targeted courses before transitioning to maintenance options.
Effectiveness can be comparable short‑term, but Tri‑Luma’s milder steroid may offer a safer profile. The “better” option depends on your skin type, tolerance, availability, and your dermatologist’s experience; safety and supervision matter more than brand.